Compounds > misonidazole

Page last updated: 2024-08-22

misonidazole and Cell Transformation, Neoplastic

misonidazole has been researched along with Cell Transformation, Neoplastic in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (54.55)	18.7374
1990's	2 (18.18)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (27.27)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G	1
Astner, ST; Bayer, C; Gaertner, FC; Nüsslin, F; Shi, K; Vaupel, P; Wilkens, JJ; Ziegler, SI	1
Ball, C; Bejot, R; Carroll, L; Elizarov, AM; Gouverneur, V; Hill, S; Kelly, C; Kersemans, V; King, RC; Kolb, HC; Miraghaie, R; Smart, S; Zhang, J	1
Hall, EJ; Miller, RC; Osmak, R; Zimmerman, M	1
Azzam, EI; Borsa, J; Einspenner, M; Raaphorst, GP; Sargent, MD	1
Hall, EJ; Miller, RC	2
Hall, EJ; He, ZY; Hei, TK; Piao, CQ	2
Hall, EJ; Hei, TK	1
Geard, CR; Hall, EJ; Hei, TK; Osmak, RS	1

Other Studies

11 other study(ies) available for misonidazole and Cell Transformation, Neoplastic

Article	Year
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Nuclear medicine communications, 2015, Volume: 36, Issue:9 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed	2015
Matching the reaction-diffusion simulation to dynamic [ Physiological measurement, 2017, Volume: 38, Issue:2 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Diffusion; Female; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Mice; Mice, Nude; Misonidazole; Models, Biological; Neoplasms, Squamous Cell; Oxygen; Positron-Emission Tomography; Tumor Hypoxia; Tumor Microenvironment	2017
Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET. Nuclear medicine and biology, 2010, Volume: 37, Issue:5 Topics: Animals; Biomarkers; Cell Hypoxia; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemical Phenomena; Drug Evaluation, Preclinical; Female; Glutathione; Kinetics; Mice; Misonidazole; Models, Biological; Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Propanols; Radioactive Tracers; Triazoles; Xanthine Oxidase	2010
Comparison of the incidence of oncogenic transformation produced by X rays, misonidazole, and chemotherapy agents. Radiology, 1982, Volume: 145, Issue:2 Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Cisplatin; Doxorubicin; Fibroblasts; In Vitro Techniques; Melphalan; Mice; Misonidazole; Nitroimidazoles; Radiation, Ionizing; Vincristine; X-Rays	1982
Effects of oxygen and misonidazole on cell transformation and cell killing in C3H 10T1/2 cells by X rays in vitro. Radiation research, 1984, Volume: 100, Issue:1 Topics: Aerobiosis; Anaerobiosis; Animals; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Dose-Response Relationship, Radiation; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents	1984
Oncogenic transformations in vitro produced by misonidazole. Cancer clinical trials, 1980,Spring, Volume: 3, Issue:1 Topics: Animals; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles	1980
Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole. British journal of cancer, 1978, Volume: 38, Issue:3 Topics: Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Misonidazole; Nitroimidazoles	1978
Mechanism of oncogenicity for bioreductive drugs. International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4 Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; Cell Line; Cell Transformation, Neoplastic; Mice; Misonidazole; Neoplasms, Second Primary; Nitrofurans; Prodrugs; Radiation-Sensitizing Agents; Risk; Tirapazamine; Triazines	1992
Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential. Radiation research, 1990, Volume: 124, Issue:1 Suppl Topics: Animals; Antineoplastic Agents; Aziridines; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents	1990
Oncogenic transforming potential of nitroimidazole radiosensitizers. International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:5 Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Etanidazole; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents	1989
In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers. International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:9 Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sister Chromatid Exchange; Time Factors	1985